DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 5.19%13.72B | 5.65%13.04B | ||||||||
Net income from continuing operations | ---- | ---- | ---- | -69.78%1.6B | ---- | ---- | ---- | ---- | -22.89%5.3B | ---- |
Operating gains losses | ---- | ---- | ---- | 120.40%3.89B | ---- | ---- | ---- | ---- | 138.42%1.77B | ---- |
Other non cash items | ---- | ---- | ---- | -2.95%-3.83B | ---- | ---- | ---- | ---- | -4.90%-3.72B | ---- |
Change in working capital | ---- | ---- | ---- | -31.01%1.45B | ---- | ---- | ---- | ---- | -39.87%2.1B | ---- |
-Change in receivables | ---- | ---- | ---- | -752.84%-1.95B | ---- | ---- | ---- | ---- | -17.40%299M | ---- |
-Change in loss and loss adjustment expense reserves | ---- | ---- | ---- | 17.78%4.64B | ---- | ---- | ---- | ---- | -21.29%3.94B | ---- |
-Change in deferred acquisition costs | ---- | ---- | ---- | 17.50%-660M | ---- | ---- | ---- | ---- | -12.99%-800M | ---- |
-Change in accrued investment income | ---- | ---- | ---- | 45.66%-194M | ---- | ---- | ---- | ---- | -3,145.45%-357M | ---- |
-Change in other current assets | ---- | ---- | ---- | -136.65%-663M | ---- | ---- | ---- | ---- | 246.00%1.81B | ---- |
-Change in other current liabilities | ---- | ---- | ---- | 487.50%2.12B | ---- | ---- | ---- | ---- | 429.41%360M | ---- |
-Change in other working capital | ---- | ---- | ---- | 41.73%-1.84B | ---- | ---- | ---- | ---- | -18,623.53%-3.15B | ---- |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 19.97%4.17B | 14.88%3.49B | 14.91%2.33B | 5.19%13.72B | 125.21%5.18B | -19.37%3.48B | -30.84%3.04B | -0.69%2.03B | 5.65%13.04B | -54.80%2.3B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 27.25%-2.16B | 78.88%-1.34B | -74.67%-2.63B | -291.07%-10.25B | 392.39%576M | 27.72%-2.97B | -400.05%-6.35B | -253.05%-1.5B | 76.58%-2.62B | 93.12%-197M |
Net investment purchase and sale | 36.49%-2.01B | 74.03%-1.79B | -505.43%-2.91B | -316.12%-8.18B | -2.22%1.15B | -21.07%-3.16B | -240.19%-6.88B | 129.39%718M | 123.18%3.78B | 135.08%1.17B |
Net proceeds payment for loan | -110.87%-79M | -2.75%992M | 112.74%223M | 95.36%-256M | 80.82%-252M | 189.42%727M | 135.47%1.02B | -238.68%-1.75B | -224.04%-5.52B | -188.31%-1.31B |
Net business purchase and sale | 35.48%-140M | 75.88%-55M | 175.89%107M | -6.49%-755M | 57.75%-169M | 42.89%-217M | -233.33%-228M | -41.00%-141M | -186.46%-709M | 56.94%-400M |
Net other investing changes | -216.67%-57M | -1,030.00%-113M | 85.57%-14M | -126.98%-143M | 47.06%-18M | -460.00%-18M | 91.30%-10M | -219.75%-97M | -36.96%-63M | -750.00%-34M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 27.25%-2.16B | 78.88%-1.34B | -74.67%-2.63B | -291.07%-10.25B | 392.39%576M | 27.72%-2.97B | -400.05%-6.35B | -253.05%-1.5B | 76.58%-2.62B | 93.12%-197M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -35.14%-1.15B | -417.94%-1.21B | 88.63%-261M | 70.45%-2.94B | 96.06%-176M | -148.65%-848M | 104.17%379M | -223.06%-2.3B | -783.48%-9.95B | -311.42%-4.47B |
Increase decrease in deposit | 18.43%-779M | 136.98%335M | 104.69%50M | 69.40%-3.28B | 91.38%-356M | -179.12%-955M | 86.01%-906M | 19.91%-1.07B | -669.84%-10.73B | -783.44%-4.13B |
Net issuance payments of debt | -82.73%172M | -198.47%-1.17B | 3,225.00%375M | -14.76%791M | 2,600.00%200M | 4.51%996M | -5,514.29%-393M | -20.00%-12M | 267.81%928M | 80.95%-8M |
Net common stock issuance | 2.27%-774M | -27.23%-855M | -50.26%-1.17B | 6.70%-3.1B | -44.13%-859M | -17.51%-792M | 39.78%-672M | 17.02%-780M | 22.71%-3.33B | 49.32%-596M |
Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Cash dividends paid | 1.96%-450M | 1.86%-423M | 2.42%-444M | 1.07%-1.76B | 0.71%-419M | 1.08%-459M | 1.37%-431M | 1.09%-455M | 3.20%-1.78B | 2.76%-422M |
Net other financing charges | 89.23%685M | -67.24%911M | 5,066.67%930M | -10.96%4.42B | 83.38%1.26B | -49.79%362M | 364.86%2.78B | -99.61%18M | 18.48%4.96B | 1,905.26%686M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -35.14%-1.15B | -417.94%-1.21B | 88.63%-261M | 70.45%-2.94B | 96.06%-176M | -148.65%-848M | 104.17%379M | -223.06%-2.3B | -783.48%-9.95B | -311.42%-4.47B |
Net cash flow | ||||||||||
Beginning cash position | 34.83%20.79B | 7.50%19.84B | 2.20%20.64B | 0.39%20.2B | -32.83%14.91B | -24.97%15.42B | -21.50%18.46B | 0.39%20.2B | -2.16%20.12B | 16.48%22.2B |
Current changes in cash | 349.57%861M | 132.26%945M | 68.42%-560M | 12.39%535M | 336.13%5.58B | -117.77%-345M | -13.53%-2.93B | -150.96%-1.77B | 1,300.00%476M | -306.82%-2.36B |
Effect of exchange rate changes | 173.75%118M | 100.91%1M | -802.94%-239M | 77.08%-91M | -59.61%145M | 44.64%-160M | 71.28%-110M | 140.48%34M | 16.95%-397M | 517.44%359M |
End cash position | 45.96%21.77B | 34.83%20.79B | 7.50%19.84B | 2.20%20.64B | 2.20%20.64B | -32.83%14.91B | -24.97%15.42B | -21.50%18.46B | 0.39%20.2B | 0.39%20.2B |
Free cash flow | 19.97%4.17B | 14.88%3.49B | 14.91%2.33B | 5.19%13.72B | 125.21%5.18B | -19.37%3.48B | -30.84%3.04B | -0.69%2.03B | 5.65%13.04B | -54.80%2.3B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |